Affordable Health Care

The cost of healthcare in the Netherlands and elsewhere is rising. Oncode is mindful of the need for new innovations in cancer therapy to reach patients at an affordable price. For this reason, Oncode focuses a substantial part of its strategy on the affordability of new medical solutions.

The Oncode approach

In order to reach these affordable healthcare goals, we set up several activities.

- One of the ways that Oncode is planning for sustainable implementation of research outputs from the very beginning, is through implementation of the Socially Responsible Licensing principlesestablished by the Netherlands Federation of University Medical Centres (NFU). Oncode participated in the relevant NFU working group and was one of the first institutes to formally endorse these principles. We are currently implementing them to make sure that new scientific insights are translated into novel therapies for patients in a responsible way.

- Oncode will ensure that 20% of its clinical activities within the Oncode Clinical Proof of Concept Programme (CPoC) will be focused on either personalized medicine (patient stratification) or drug repurposing. In partnership with the Netherlands Organisation for Health Research and Development (ZonMW), Oncode will award several CPoC projects dedicated to affordable healthcare research. One project has already been awarded, two additional affordable healthcare clinical projects are currently under evaluation.

- Drug repurposing is an effective approach to rapidly identify novel indications for known drugs and compounds. In order to support researchers in bringing novel therapeutic applications to the patient at affordable costs, Oncode has initiated the Drug Repurposing Programme. The goal of this programme is to stimulate research that re-purposes abandoned, off-patent, or patent expiring drugs.

Tale Sliedrecht Programme Manager

Related news and events

Oncode Icons Square 14
A cost-effective treatment strategy for metastatic colorectal carcinoma patients
The sustainability of the healthcare system is under extreme pressure, given the increasing costs associated with research, drug development, treatment and hospital care. Through support of its Investigators’ research and development activities, Oncode is working to advance new and innovative therapies to patients.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Thumbnailt5Gr2Nz3
Socially Responsible Licensing at Oncode Institute
Oncode is planning for sustainable implementation of research outputs from the very beginning through implementation of the Socially Responsible Licensing policies.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.